Collagen-targeted PET/CT imaging of tuberculosis patients
- PMID: 40639875
- DOI: 10.1183/13993003.00195-2025
Collagen-targeted PET/CT imaging of tuberculosis patients
Conflict of interest statement
Conflict of interest: S.B. Montesi reports grants from Pliant Therapeutics and Boehringer Ingelheim, consultancy fees from Accendatech USA, DevPro Biopharma, Mediar Therapeutics and Roche, payment or honoraria for lectures, presentations, manuscript writing or educational events from Cowen, royalties or licences from Wolters Kluwer, and participation on a data safety monitoring board or advisory board with APIE Therapeutics and Pliant Therapeutics. P. Caravan reports consultancy fees from Collagen Medical LLC, Reveal Pharmaceuticals and Fering Ventures, stock (or stock options) with Collagen Medical LLC and Reveal Pharmaceuticals, and patents planned, issued or pending (US patent US10,471,162, which includes 68Ga-CBP8). The remaining authors have no potential conflicts of interest to disclose.
Publication types
LinkOut - more resources
- Full Text Sources
 
        